RG-7600

N/A

Report date: 2024/02/05 13:59:09

Base Information

Drug NameRG-7600
Drug Alias NameDMOT-4039ARG-7600
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTubulin polymerisation inhibitorsMesothelin inhibitors
TargetsMesothelinTubulin
Therapy Area/IndicationsOvarian DiseasesAdnexal DiseasesPancreatic Diseases +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsOvarian DiseasesAdnexal DiseasesPancreatic Diseases +[7

Other Information

ATC CodeN/A
Related LinksN/A